premedication 60-90 minutes before surgery , Moore & Hollis 1968 . The author reports the oral use of diazepam to enhance sedation, without increasing the respiratory depression of conventional premedicants, prior to cardiac surgery. A satisfactory oral dose of diazepam is 0-32 mg/kg body weight.
Oral diazepam is used for premedication in children (Dowell 1966) ; however, a relatively higher dosage is frequently required (up to 0 64 mg/kg body weight). For intramuscular premedication an average dose of 0-32 mg/kg body weight may be used one hour preoperatively (Tornetta 1965 , Haslett & Dundee 1968 ). Diazepam 10 mg intramuscularly prior to neurosurgery gave satisfactory results (Bozza Marrubini & Tretola 1965) .
As an intravenous premedication immediately prior to surgery, diazepam 0-1-016 mg/kg body weight is used. This technique is advocated for procedures under local anesthesia (Huguenard & Margelidon 1964 , Moore 1968 ).
Induction of Anesthesia
Diazepam may be used as an intravenous induction agent, particularly for poor-risk cases. However, a wide variation in dose requirement is observed (Brown & Dundee 1968) . The author uses up to 0-32 mg/kg body weight, followed by an inhalational agent if necessary. Patients rarely recall this, because of associated amnesia.
Intravenous diazepam induction prior to cardioversion has the advantages of less cardiovascular depression and less cardiac irritability compared with thiopentone (Kernohan 1966 , Muenster et al. 1967 .
Dental Practice
Oral diazepam has been used for sedation of ambulant patients (Peabody 1965 , Lipkin 1968 ), whilst intravenously it has been advocated as a simpler alternative to the Jorgensen technique (Murray Lawson 1968 ).
Obstetrics
As sedation in labour, diazepam has not adversely affected the Apgar score of the infants (Bepko et al. 1965 , Nisbet et al. 1967 . Its use in the control of eclamptic fits has resulted in a reduced neonatal mortality when compared with other forms of sedation (Lean et al. 1968 ). It is suggested that diazepam be considered for the premedication of obstetrical cases.
Diagnostic Procedures
Sedation with diazepam has given good conditions for cardiac catheterization under local anesthesia (Desmeules & Morin 1967) . The author reports the use of oral diazepam with intramuscular papaveretum and promethazine 064 mg/kg body weight of each, as basal sedation for cardiac catheterization in children.
Intensive Care Diazepam has been used in large doses to control convulsions in tetanus (Femi Pearse 1966 , O'Donohoe 1967 , and in the control of status epilepticus, when repeated 10 mg doses are given intravenously (Parsonage & Norris 1967 , Wilson 1968 ). The use of 2-5-5-0 mg intravenous doses in the control of patients undergoing artificial ventilation is reported.
Dr D A Cahal

(Committee on Safety ofDrugs, Lonidon)
Clinical Trials of Analgesic Drugs In this paper an analgesic drug will be regarded as one which, in therapeutic doses, will relieve pain by an action on the central nervous system without at the same time interfering with consciousness or the perception of sensations other than pain.
One of the first problems encountered by the clinical investigator of analgesics is likely to be has produced the first drug to be able to produce va molecule more quickly th evaluate them. In the wI first member of one partii short-acting. By the time thi a further four in the series From the animal data avail best candidates were sel clinically. By the time these 1 over a hundred variants c room to try to equate the severity and nature of a lesion with the patient's grading of his pain.
Next comes the design of a trial. Does one include a dummy or not? I think not. The ethics of such a procedure are doubtful and the scientific value of such an inclusion is also doubtful. The DIPIPANONE proper control in clinical trials of analgesics is a known analgesic. Various estimates of the incidence of placebo reaction have been made and the statement is often made that 30-60% of patients are 'placebo reactors'. It is worth remembering that the same result would be achieved if all of us were 'placebo reactors' 30-60% of the time.
The choice of dose in the initial stages of a trial can be difficult with only animal data to go 20 30 50 on. It is worth remembering that in the usual laboratory tests for analgesia the dose of morphine required to demonstrate analgesic effect in rats is of the order of 4 mg/kg body weight. This dose would have disastrous effects For when the chemist in man! in a series he is likely
In Fig 1 is seen a comparison in patients Lriations of the basic between methadone hydrochloride and dipian the clinician can panone hydrochloride. The slope for dipipanone riter's experience the does not at first sight make sense. Statistically, cular group was too however, the line should be regarded as is had been discovered horizontal, for the difference in response to the had been produced. two doses used is not significant. Therefore, it is [able on these the two reasonable to assume that the doses chosen were lected for screening not on the steepest portion of the dose-response two had been screened curve. Lack of side-effects made it likely that the )f the basic molecule doses were at the lower end of the curve. had been produced.
Evaluation of analgesics in man is essentially dependent on subjective evaluation by the person to whom they are administered. Twelve years ago I worked on healthy volunteers. This was a slow business, for to minimize the risk of producing dependence long intervals had to elapse between doses. Drug dependence in society today has increased so much that I would hesitate to give any major analgesic to healthy volunteers for fear of producing it, particularly in students.
Keele's work on pain charts is well known and is still, to my mind, the best way of evaluating an analgesic. I have, however, some suggestions regarding these charts:
(1) The patient should be given four grades of pain to choose from. 'Pain or no pain', or rather 'relief or no relief' as an evaluation by the patient causes bias. The patient likes to please the doctor, and an over-estimate of efficacy results.
(2) Three grades of pain to choose from produce a loading on the middle grade.
(3) Before a trial, it is worth finding out what local terms mean, e.g., a 'nague' in Leeds is not a severe pain but an uncomfortable nag. It is worth following patients to the theatre or post-mortem Post-operative pain has been used by many, notably Beecher, to evaluate analgesics. This is all very well but one must remember that postoperative pain limits itself in duration quite rapidly so one does not have the opportunity of giving many doses of the drug under investigation to a single patient. Moreover, on careful enquiry, it is surprising how few patients really require a potent analgesic after abdominal surgery. One has the distinct impression that in such cases the most common indication for giving a potent analgesic is that it was written on the warding slip! Again in such cases one must be careful to compare like with like. The pain after cholecystectomy tends to be more severe than, say, that experienced after appendicectomy.
This brings me to my final point. An experimental design -which has been neglected involves sequential analysis. To use this technique involves reducing the patient's assessment of a drug's activity to 'better or worse'. This cannot be left entirely to the patient for reasons given earlier. The problem can, however, be resolved by giving the patient four grades of pain to choose from and counting any improvement simply as 'better'. But one must pair patients off. I have used the technique in obstetrics, pairing patients according to age and parity. There seems no reason why this should not also be done with post-operative pain but again it must be stressed that like must be compared with like. It must also be realized that in using this technique many patients are lost to the trial, usually because a pair ends up incomplete. For instance, in a trial carried out by Dare, Keith and myself a significant result was achieved after apparently eleven pairs of patients had taken part in the trial. In fact, however, over 50 patients were lost to the trial so that the sequential design is not always as swift and economical as one might wish.
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Professor J W Dundee (Belfast) said that the use of dummy preparations was essential in clinical studies of analgesic drugs when one was testing a method of study or examining its sensitivity. The observer himself could only act as a placebo by extra attention to the patient, and it was known that some workers got greater degrees of pain relief than others because of this.
Dr A R Hunter (Manchester) said diazepam was undoubtedly of value in controlling status epilepticus and produced relatively little disturbance of blood pressure or respiration in those circumstances. When, however, it was given to anesthetized patients the results might be different. In those under nitrous oxide, oxygen and halothane it was capable of producing profound respiratory depression, if not apncea. It also lowered the blood pressure in occasional cases. In patients under nitrous oxide, and oxygen alone, respiratory depression and a minor degree of blood pressure fall might follow its administration.
Professor B Simpson (London) asked Dr Brown whether he really believed that pentazocine was a potent analgesic, since the reports of a number of clinical trials suggested otherwise.
Dr Brown replied that he used pentazocine for neuroleptanalgesia in certain operations including pneumoencephalography. Complete relief of pain was obtained with doses of pentazocine that did not depress respiration. Under similar conditions neither morphine nor pethidine provided complete relief of pain.
Dr B Kay (Derby) had found that pentazocine (50 mg) was a satisfactory analgesic for production of neuroleptanalgesia with dropiderol, similar in effect to phenoperidine (1 -25 mg) but with a shorter duration of action. Unlike Dr Brown, he had found the two drugs produced comparable respiratory depression.
Dr R Binning (Brighton) asked how one could be certain that pentazocine was non-addicting. Dr Brown said this was only a supposition, but he accepted the findings of the WHO expert committee on dependence-producing drugs (1966) and the absence of evidence to the contrary in the literature.
Dr G F Blane (Hull) was surprised at Dr Brown's statement that pentazocine was as effective an analgesic as morphine or pethidine. This was at variance with many clinical reports. He asked why dysphoria was not seen with pentazocine.
Dr Brown said the absence of dysphoria was probably due to the suppressant action of haloperidol and droperidol.
